Scholarlink

Purpose of Review <p>Radiotherapy serves as a palliative option for alleviating cancer pain but can also elicit chest wall pain following stereotactic body radiotherapy (SBRT). The etiology of chest wall pain remains unclear but may relate to SBRT effects on normal ribs and responses from activated osteoclasts. This review explores potential mechanisms and treatment strategies for this increasingly common complication for patients undergoing radiotherapy.</p> Recent Findings <p>Radiation-induced bone loss is likely multifactorial, involving changes to bone microvasculature, suppressed angiogenesis, osteoblast damage and senescence, as well as increased resorption via activated osteoclasts. Preliminary data suggest that inhibiting osteoclasts may prevent radiation-induced chest wall pain and rib fracture. Our laboratory has identified TGF-βR1 as a potential central mediator of radiation-induced bone loss and pain signaling between osteoclasts and sensory neurons.</p> Summary <p>Advances in radiotherapy have optimized tumor targeting and control. However, radiation-induced musculoskeletal toxicity remains prevalent. Recent findings suggest targeted inhibition of TGF-β signaling between osteoclasts and neurons may offer a therapeutic strategy to mitigate radiation-induced pain.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Novel Insights into Mechanisms of Pain Caused by Radiotherapy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月25日

查看全文
  • Jeffrey A. Foster,
  • Sun H. Park,
  • Joseph Moore,
  • Kaitlyn E. Reno,
  • Alicia Costa-Terryll,
  • Leslie Kim,
  • Michael T. Munley,
  • Jeffrey S. Willey

摘要

Purpose of Review

Radiotherapy serves as a palliative option for alleviating cancer pain but can also elicit chest wall pain following stereotactic body radiotherapy (SBRT). The etiology of chest wall pain remains unclear but may relate to SBRT effects on normal ribs and responses from activated osteoclasts. This review explores potential mechanisms and treatment strategies for this increasingly common complication for patients undergoing radiotherapy.

Recent Findings

Radiation-induced bone loss is likely multifactorial, involving changes to bone microvasculature, suppressed angiogenesis, osteoblast damage and senescence, as well as increased resorption via activated osteoclasts. Preliminary data suggest that inhibiting osteoclasts may prevent radiation-induced chest wall pain and rib fracture. Our laboratory has identified TGF-βR1 as a potential central mediator of radiation-induced bone loss and pain signaling between osteoclasts and sensory neurons.

Summary

Advances in radiotherapy have optimized tumor targeting and control. However, radiation-induced musculoskeletal toxicity remains prevalent. Recent findings suggest targeted inhibition of TGF-β signaling between osteoclasts and neurons may offer a therapeutic strategy to mitigate radiation-induced pain.